You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤
Overview
In The News
Executives & Employees
Board of Directors
Paths
Recent Transactions
Transaction Advisors
Investments
Investors
Suppliers

Kedrion S.p.A.

Overview

Date Founded
2001
Headquarters
Localita Ai Conti, Castelvecchio Pascoli, Barga, Lucca 55051
Industries
Pharmaceuticals

Holding Companies

Biotechnology
Company Description
Kedrion SpA develops and markets biopharmaceutical products. It operates as a biopharmaceutical company which specializes in the development, production, and distribution of plasma-derived products. The firm collects and fractionates blood plasma to produce and distribute plasma-derived therapeutic products for use in treating serious diseases, disorders and conditions such as hemophilia and immune system deficiencies. It serves medical and scientific, and institutional patient communities worldwide. The company was founded in 2001 and is headquartered in Barga, Italy.
Website

In The News See More

Business Wire
January 22, 2018
Business Wire
October 24, 2017
Business Wire
October 12, 2017
PR Newswire
May 29, 2017
Business Wire
April 4, 2017
See full news coverage and complete stories with RelSci Professional.

Executives & Employees


Chairman & Chief Executive Officer

Chief Financial Officer

Chief Operating Officer

Chief Commercial Officer

Chief Regulatory & Compliance Officer

General Manager

Vice Chairman

Director-Quality Assurance

Director-Plasma Business Unit

Director-Global Supply Chain
See our list of current and previous employees when you upgrade.

Board of Directors


Chairman & Chief Executive Officer at Kedrion S.p.A.

Vice Chairman at Kedrion S.p.A.

Chief Operating Officer at Global Engineering & Construction Group

Former Partner at Investitori Associati Sgr SpA

Director at Kedrion S.p.A.

Director at Kedrion S.p.A.

Co-Founder at Investitori Associati SpA

Former Partner at Investitori Associati Sgr SpA
See our list of current and previous board members when you upgrade.

Paths to Kedrion S.p.A.

Kedrion S.p.A.
You
Connections via Relationship Science
Kedrion S.p.A.
Sync your contacts to see how you can connect with Kedrion S.p.A..

Recent Transactions

Details Hidden
Groupe Marcucci SA purchases Kedrion S.p.A.
Details Hidden
Kedrion S.p.A. purchases Ortho Clinical Diagnostics, Inc. /RhoGam Business from Johnson & Johnson
Details Hidden
Kedrion S.p.A. purchases Grifols SA /US Fractionation FVII & Plasma Collection Bus from Grifols SA - (Pending)
Details Hidden
Kedrion S.p.A., IMI Fondi Chiusi SGR SpA, Alcedo SGR SpA purchase Hardis SpA

Transaction Advisors

Companies ▾
Legal Advisor
Advised on Kedrion S.p.A. purchases Grifols SA /US Fractionation FVII & Plasma Collection Bus from Grifols SA

Investments

Details Hidden
Hardis SpA manufactures pharmaceutical products. The company specializes in the production of immunoglobins and inactive blood plasma for transfusion usage. The company was founded in 2000 and headquartered in Sant'Antimo, Italy.

Investors

Details Hidden
Details Hidden
CDP Equity is an active, long-term manager which invests in strategic companies with net annual turnover of at least EUR 240 million and an average of at least 200 employees which operate in the defense, security, infrastructure and public services, transportation, communication, energy, insurance and financial intermediation, research and high technology sectors, aiming to achieve market returns through a combination of dividends and capital gains.The firm invests in companies seeking to expand, improve operational efficiency and strengthen their competitive position in both domestic and international markets. They typically acquire minority interests in companies of major national interest with a sound financial position, adequate profitability and growth prospects. They are also open to working with co-investors on investment deals and play an active role in the governance of their investee companies.CDP Equity establishes appropriate mechanisms to ensure the liquidity and monetization of their investments in order to preserve, leverage and make the capital provided by shareholders available for the future. A typical investee company shareholder agreement provides for representation on the Board of Directors, rights regarding key operational matters and extraordinary corporate initiatives and agreement on the business plan and various initiatives.Their investment process involves transparent decision making. Each investment must be approved by the firm's Investment Committee and Board of Directors.
Details Hidden
IA invests in the Italian mid-market segment across industrial, commercial and service sectors. In partnership with the portfolio firm's management, IA's investment objective is to create value. They look for transaction values of at least €100 million. They typically acquire 100% or a controlling stake of the portfolio firm, either independently or in partnership with other investors. IA also takes minority stakes in special situations where the exit strategy is clearly defined and viable.IA considers three types of private equity investments: leveraged acquisitions with investments in market- or niche-leading firms having robust cash-flows and stable performances; turnaround situations with financing in underperforming firms which have identified re-launch strategies and restructuring policies; development capital for firms with clearly defined growth plans through specific industrial projects.Within their targeted industry sectors, the firm has specifically invested in diverse areas such as publishing, automotive components, textile machinery, radiology equipment, biodegradable materials, online trading, packaging, pharmaceutical logistical services, food, sportswear, rubber and plastic, and distribution.IA is an active investment manager. In addition to financial support, they provide management expertise through strategy definition and access to their network of industry experts.
Details Hidden
IMI FC SGR's investment strategy focuses on small and mid-size firms located in Northern and Central Italy. They provide capital for expansions, buyouts and replacement transactions.In addition to capital infusions, the firm supports entrepreneurs with strategic development expertise and financial consulting. They typically invest EUR 1-10 million per transaction.
Details Hidden
Alcedo is a private equity investment manager specialized in growth capital in Italy. The firm invests in small to medium-sized profitable companies in Italy, and targets established family-owned businesses. They invest in companies valued around 120 million Euros. Alcedo focuses on high-growth sectors where Italian leadership is internationally recognized, such as niche industrial applications, design and high-end branded goods. They aim to invest in companies with a defensible business, downside protection and a high cash conversion rate.Alcedo acquires majority or significant minority stakes, and prefers to have minimal recourse to leverage. They foster the strategic repositioning and sustainable growth of their portfolio companies. The firm sources deals through their established network in the business and financial community at the regional level. Their targeted exit horizon is four to five years.

Suppliers

   Pharmaceuticals    Barcelona, CT
Grifols SA is a vertically integrated global producer of plasma derivatives. Its activities include sourcing raw material, manufacturing various plasma derivative products and selling and distributing final products to healthcare providers. The company operates through the following segments: Bioscience, Hospital, Diagnostic and Raw Materials. The Bioscience segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic segment includes the marketing of diagnostic testing equipment, reagents, and other equipment. The Raw Materials segment includes the sale of intermediate biological products and the rendering of manufacturing services to third party companies. Grifols was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.
   Appliances & Electronics    Egham, SU
Spectris develops and markets productivity-enhancing instrumentation and controls. The company had sales of £1,106.2 million in 2011 and employs around 7,600 people worldwide. Spectris is listed on the London Stock Exchange (symbol – SXS) and is a member of techMARK, the London Stock Exchange’s index for technology companies, and the FTSE4Good index of socially-responsible companies.
   Internet Software & Services    Milan, MI
FullSix SpA engages in the provision of innovation and digital communication services. It operates through the following business segments: Digital, System, and Technology. The Digital segment offers personalized media and research solutions such as advertising budget planning and implementation of social media marketing strategies. The System segment includes activities related to mobile telephony and infrastructure services. The Technology segment provides technical implementation and platform integration. The company was founded on January 11, 1988 and is headquartered in Milan, Italy.

You've reached your 7 free profiles limit this month.

Upgrade to RelSci Pro today to enjoy unlimited profile views and much more!

Start My Free Trial
Still not convinced? Check out our full listing of features here.